ZYTIGA
JANSSEN INC
Quick answers
Is there a shortage of ZYTIGA in Canada?
No. There is no current shortage of ZYTIGA 250MG reported to Health Canada. Stock can still vary from one pharmacy to another.
Other Products Containing the Same Active Ingredient
These are other Health Canada-approved human drug products containing the same active ingredient, not currently reported in shortage. Strength, dosage form, and route can still differ — ask your pharmacist whether any of these are appropriate for you. This isn't a guarantee of current stock.
Closest Matches
MAR-ABIRATERONE
MARCAN PHARMACEUTICALS INC
REDDY-ABIRATERONE
DR REDDY'S LABORATORIES LTD
EUGIA-ABIRATERONE
EUGIA PHARMA INC.
MINT-ABIRATERONE
MINT PHARMACEUTICALS INC
RIVA-ABIRATERONE
LABORATOIRE RIVA INC.
SANDOZ ABIRATERONE
SANDOZ CANADA INCORPORATED
DIN
02371065
Strength
250MG
Dosage Form
Tablet
Route
Oral
Compare with another product →
Shortage History
No shortage or discontinuation reports on file for this product.
Other Products from JANSSEN INC
Other Health Canada-approved products made by the same manufacturer — not necessarily related to this shortage, and not necessarily in shortage themselves.
DIN 02538563
DIN 02538555
4MG · DIN 02493225
3MG · DIN 02493217
5MG · DIN 02493233
0.5MG · DIN 02397447
1.5MG · DIN 02397455
18MG · DIN 02247732
54MG · DIN 02247734
27MG · DIN 02250241
36MG · DIN 02247733
400MG · DIN 02455978